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Abstract
Background: Modeling count and binary data collected in hierarchical designs have increased the use of Generalized Linear
Mixed Models (GLMMs) in medicine. This article presents a systematic review of the application and quality of results and
information reported from GLMMs in the field of clinical medicine.
Methods: A search using the Web of Science database was performed for published original articles in medical journals
from 2000 to 2012. The search strategy included the topic ‘‘generalized linear mixed models’’,‘‘hierarchical generalized linear
models’’, ‘‘multilevel generalized linear model’’ and as a research domain we refined by science technology. Papers reporting
methodological considerations without application, and those that were not involved in clinical medicine or written in
English were excluded.
Results: A total of 443 articles were detected, with an increase over time in the number of articles. In total, 108 articles fit the
inclusion criteria. Of these, 54.6% were declared to be longitudinal studies, whereas 58.3% and 26.9% were defined as
repeated measurements and multilevel design, respectively. Twenty-two articles belonged to environmental and
occupational public health, 10 articles to clinical neurology, 8 to oncology, and 7 to infectious diseases and pediatrics.
The distribution of the response variable was reported in 88% of the articles, predominantly Binomial (n = 64) or Poisson
(n = 22). Most of the useful information about GLMMs was not reported in most cases. Variance estimates of random effects
were described in only 8 articles (9.2%). The model validation, the method of covariate selection and the method of
goodness of fit were only reported in 8.0%, 36.8% and 14.9% of the articles, respectively.
Conclusions: During recent years, the use of GLMMs in medical literature has increased to take into account the correlation
of data when modeling qualitative data or counts. According to the current recommendations, the quality of reporting has
room for improvement regarding the characteristics of the analysis, estimation method, validation, and selection of the
model.
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Introduction
Statistical modeling is a highly important tool that receives a lot
of attention in any scientific field. In health sciences, statistical
models arise as an important methodology to predict outcomes
and assess association between outcomes and risk factors as well.
Thus, one important aspect is to efficiently test the investigational
hypothesis by avoiding biases and accounting for all the sources of
variability present in data. This usually leads to complex designs
where data is hierarchically structured. Multilevel, longitudinal or
cluster designs are examples of such structure. In health sciences,
longitudinal studies probably are more common, where measure-
ments are grouped in subjects who are followed over time.
Furthermore, other possibilities are studies where measurements
are hierarchically grouped in subgroups such as schools, hospitals,
neighborhoods, families, geographical areas or place of employ-
ment.
In the classic linear model (linear regression analysis, ANOVA,
ANCOVA), the variable response is continuous and it is assumed
that the response conditioned to covariates follows a normal
distribution with maximum likelihood based approaches as the
principal estimation methods [1–3]. However, the general linear
model is not appropriate for non-continuous responses (e.g.
binary, counts) because the underlying assumptions of the model
do not hold.
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Generalized linear models (GLMs) arose as an extension of the
classic linear model that allowed for the accommodation of non-
normal responses as well as a non-linear relationship between the
expectation of the response and the covariates [2,4,5]. GLMs are
most often applied to count or binary responses in health sciences
[6], assuming Poisson, Binomial or Bernoulli as probability
distributions for the response.
Similar to the classic linear model (which is indeed a particular
type of GLM), GLMs also assume that the observations
(conditioned to covariates) are independent and identically
distributed. Regarding study designs with hierarchical structure,
the assumption of independence is usually violated because
measurements within the same cluster are correlated. The main
disadvantage of ignoring within-cluster correlation is the bias in
point estimates and standard errors. These biases might cause a
loss of statistical power and efficiency of hypothesis testing on fixed
effects [7,8]. Thus, the statistical significance could be wrongly
assessed [9] and the type I error rate could be different than that a
priori determined in hypothesis testing.
Generalized linear mixed models (GLMMs) are a methodology
based on GLMs that permit data analysis with hierarchical GLMs
structure through the inclusion of random effects in the model.
The GLMMs are also known in the literature as hierarchical
generalized linear models (HGLMs) and multilevel generalized
linear models (MGLMs) depending on the field [10–12]. For the
sake of simplicity we will use the term GLMMs throughout the
text. The first estimation method of GLMMs was introduced in
the early 1990 s [13]. Nowadays various estimation methods can
be found for GLMMs, such as the penalized quasi-likelihood
method (PQL) [14], the Laplace method [14], Gauss-Hermite
quadrature [15], hierarchical-likelihood methods [11], and
Bayesian methods based on the Markov chain Monte Carlo
technique [16,17], and, recently also based on the integrated
nested Laplace approximation [18].
Furthermore, GLMM methodology is now available in the
main statistical packages, though estimation methods as well as
statistical packages are still under development [19,20].
The increasing interest in GLMMs is reflected by the
publication of tutorials in various fields, such as ecology [19],
psychology [21], biology [22], and medicine [23–26]. Nowadays,
original articles, academic work and reports which utilize GLMMs
exist, and methodological guidelines and revisions are also
available for the analysis of GLMMs in each field [19,27–29].
However, it is not possible to find guidelines that specifically
address the appropriate reporting of population modeling studies
[30]. In addition, no reviews of the use and quality of reported
information by GLMMs exist despite an important increase in
quantitative analyses in the academic and professional science
settings.
Reporting guidelines are evidence-based tools that employ
expert consensus to help authors to report their research such that
readers can both critically appraise and interpret study findings
[30–34]. Recently, minimal rules that can serve as standardized
guidelines should be established to improve the quality of
information and presentation of data in medical scientific articles
[35]. Only Thiele [22] has made reference to GLMMs in the field
of biology and still no standardized guidelines indicate what
information is relevant to present in medical articles.
For this reason, the objective of the present study is to review
the application of GLMMs and to evaluate the quality of reported
information in original articles in the field of clinical medicine
during a 13-year period (2000–2012), while analyzing the
evolution over time, journals, and areas of publication.
Methods
This review was conducted according to the Preferred
Reporting Items for Systematic Reviews and Metanalyses
(PRISMA) Statement [36,37]. We also report the review in
accordance with PRISMA guidelines (Checklist S1).
With the objective to obtain and analyze the existing scientific
literature related to the use of GLMMs in clinical medicine, a
strategic search of original published articles in this field from 2000
to 2012 was performed using the Web of Science database.
The search strategy included the topic ‘‘generalized linear mixed
models’’, ‘‘hierarchical generalized linear models’’, ‘‘multilevel
generalized linear model’’ and as a research domain we refined
by science technology (Appendix S1).
The following fields of clinical medicine were included in the
search:
Endocrinology Metabolism, Urology Nephrology, Public envi-
ronmental occupational health, Orthopedics, Respiratory system,
Entomology, Health care sciences services, Medical laboratory
technology, Pediatrics, Pathology, Life sciences biomedicine other
topics, Hematology, Geriatrics gerontology, Gastroenterology hepa-
tology, Rheumatology, Critical care medicine, Medical informatics,
Emergency medicine, Integrative complementary medicine, Obstet-
rics gynecology, Neurosciences neurology, Cardiovascular system
cardiology, Infectious diseases, Radiology nuclear medicine medical
imaging, Transplantation, Tropical medicine, Allergy, Anesthesi-
ology, Anatomy morphology, General internal medicine, Immunol-
ogy, Research experimental medicine, Dermatology, Oncology,
Surgery.
Selection of the studies included in the review
Articles were eligible for inclusion if they were original research
articles written in English in peer-reviewed journals reporting an
application of GLMM. We excluded articles of statistical
methodology development and those that were not entirely
involved in clinical medicine (biology, psychology, genetics, sports,
dentistry, air pollution, education, economy, family and health
politics, computer science, ecology, nutrition, veterinary and
nursing).
Identification of studies
The information from Appendix S1 (Table) was extracted from
the selected articles. Data were collected and stored in a database.
Then, data were checked to find discrepancies between the two
reviewers. Discrepancies were solved by consensus after reviewing
again the conflictive articles.
Figure 1 uses the PRISMA flowchart to summarize all stages of
the paper selection process [37]. In the first review phase, 462
articles were identified, nineteen of which were duplicates.
After inspection of the abstracts, we excluded the articles that
were non-original articles (reviews, short articles or conferences)
and those articles that did not have a GLMM as a key word in the
abstract or in the title of the article.
In the second review phase, of the 428 articles, only 129
pertained to the aforementioned medical fields. Thus, 299 articles
were excluded because they belonged to other fields, such as
ecology, computer science, air pollution or statistical methodology.
In the third review phase, we obtained full text versions of
potentially eligible articles. Two articles were excluded due to
inconsistency in the specification of the model applied because in
the full text version they were not a GLMM as it was stated in the
abstract. We then conducted a detailed review of the 127 articles
and we excluded 19 articles because they were not published in an
indexed journal included in Journal Citation Reports (JCR).
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Finally, 108 articles were included in the final review (Appendix
S2). Figure 1 summarizes the numbers of articles identified and
the reasons for exclusion at each stage.
Information collected from the selected articles
Based on Thiele’s and Bolker’s works [22,38], a list of relevant
information and basic characteristics of the study that should be
reported in an article with GLMM analysis was suggested
(Appendix S1).
Figure 1. Flow chart of the selection of reviewed articles.
doi:10.1371/journal.pone.0112653.g001
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Study characteristics
Regarding the study design, we refer to different aspects of each
study, such as hierarchical structure of data and sample size. The
hierarchical structure was used to differentiate between the
different study designs that are not mutually exclusive, such as
longitudinal, repeated measurements, and multilevel studies.
Longitudinal data consist of outcome measurements repeatedly
taken on each experimental unit over time. Longitudinal analysis
is distinct from cross-sectional analysis as it addresses dependency
among measurements taken on the same experimental unit [39].
The studies with repeated measurements usually involve only one
level of clustering, where the repeated measurements are
interchangeable (replicates).
Finally, multilevel studies present various levels of clusters,
potentially providing hierarchical structure in each cluster, as seen
in longitudinal or repeated measurement studies. We also took
note of whether the probability distribution of the variable
response was mentioned or easily deducible. Regarding sample
size, the number of clusters, individuals or experimental units were
collected.
Inferential issues
This section includes information regarding the GLMM model,
as seen in Appendix S1 (Table).
The mixed models are characterized by including fixed and
random effects in the linear predictor. Random effects are usually
related to the cluster variable. Therefore, it is important to provide
information about the cluster variable in the model.
It is also important to report the estimation method of the study
and the software applied because they can influence the validity of
the GLMM estimates [6,20,38]. Furthermore, the software
implementations differ considerably in flexibility, computation
time and usability [20].
Concerning the computational issues, the macro GLIMMIX
from SAS (1992) was the first available software to fit GLMMs
using penalized quasilikelihood (PQL) estimation method. The
first production version of PROC GLIMMIX for SAS was first
released in 2005 and became the standard procedure in version
9.2 in 2008 [40]. Nowadays, there are other available softwares to
fit GLMMs. Among them the lme4 package was first implemented
for R in 2003 [41]. Moreover, in R software, we can find other
packages to fit GLMMs such as glmmML [42], MASS (with the
glmmPQL function) [43] or gar (with the repeated function)
[44,45]. Concerning SAS software besides the aforementioned
PROC GLIMMIX, the PROC NLMIXED is also able to fit
GLMMs [46]. Additionally, it is also possible to use ASReml [47],
MLwiN [48] and STATA software (which uses the functions
xtmixed and gllamm [22,28,49,50]) [22,28,49,50]. The SPSS
(starting with SPSS 19) software now also includes a GLMM
obtained in the GENLINMIXED procedure [51,52].
With respect to statistical inference, the hypotheses concerning
fixed and random effects (or their variances) are tested in separated
form. Thus, testing the hypotheses for fixed effects is commonly
assessed by the Wald score tests. On the other hand, hypotheses
concerning random effects variances can be tested using the
likelihood ratio test [19] or by comparing the goodness of fit of the
models using the Akaike’s Information Criterion (AIC) or the
Bayesian Information Criterion (BIC) [19].
Validation model
Similar to GLMs, validation of GLMMs is commonly based on
the inspection of residuals to determine if the model assumptions
are fulfilled.
An important point is related to the so-called scale parameter
when it is fixed to a specific value because of the probability model
assumed. For example, the scale parameter for Poisson and
Binomial distribution should be equal to 1. A parameter different
from 1 implies that the probability distribution of the responses
conditioned to covariates is not correctly specified and the model is
not valid. This phenomenon is known as over or underdispersion
and causes incorrect standard errors that can produce different
clinical conclusions [53]. Thus, it is relevant to evaluate the
presence of over- or underdispersion and report the results of this
analysis.
Finally, information on the use of a concrete strategy to select
the variables in the model and its criterion was obtained. Variable
selection strategy usually consist of stepwise selection of variables
(forward or backward) [19]. Concerning the criterion, it can be
based on entropy as the aforementioned AIC and BIC, or
hypotheses testing (likelihood ratio test or Wald test). However, it is
possible to find studies with no need of variable selection, for
example confirmatory analysis where a particular hypothesized
model is fit. This hypothesized model may be based on theory
and/or previous analytic research [54,55]. In this latter case, the
selection variable strategy was considered appropriately reported.
Results
The evolution of the use of GLMMs in medical journals of the
443 articles selected in the first phase is described in Figure 2. The
remaining results (Tables 1, 2, 3 and Appendix S3 and S4) make
reference to the 108 articles included in the final in-depth review.
Of these, 92 (85.2%) were defined as GLMMs, 14 (13.0%) as
HGLMs, and 2 (1.9%) as MGLMs.
Most of these articles were found in the following journals:
American Journal of Public Health, which had 7 publications;
PLoS ONE, Cancer Causes & Control, BMC Public Health,
Annals of Surgery, and Headache, which had 3 publications each.
Twenty-two articles pertained to environmental and occupational
public health area, 10 articles pertained to clinical neurology, 8 to
oncology, and 7 to infectious diseases and pediatrics (Appendix
S3).
Forty-five articles (41.7%) were written by an author who was
part of a biometric or statistical department and some co-authors
(53.3%) were affiliated with a public health department.
Of the 108 selected articles, 59 (54.6%) declared to be
longitudinal studies, whereas 56 (58.3%) and 29 (26.9%) were
defined as repeated measurements and multilevel design, respec-
tively (Table 1). It is important to note that over 8% of the articles
were unclear when reporting the cluster design. Twenty-seven
articles (25%) involved confirmatory analysis whereas 81 (75%)
were declared as exploratory analysis. Ninety-five of the articles
stated their sample size, which ranged from 20–785,385 with a
median of 2,201 (Q1 = 408; Q3 = 25000). One random effect in
the intercept was used in 61 articles, and two or more random
effects were used in 36 articles. Of these, 61.1% of the articles had
a random effect that pertained to a multilevel model. The size of
the random effect or cluster, as the number of levels of random
effects or the number of clusters, was clearly described in only 33
articles, which ranged from 9–16,230 clusters with a median of
167 (Q1 = 55; Q3 = 1187). The cluster was principally the
individual (subject, patient, participant, etc) (n = 46), hospital
(n = 15), center (n = 10), geographical area (n = 9) and family
(n = 3).
The type of study design was described as cross-sectional
(n = 31), cohort (n = 26), clinical trial (n = 18), case-control (n = 2)
and cross-over (n = 1). Eight articles did not mention study design
A Systematic Review of GLMMs in Clinical Medicine
PLOS ONE | www.plosone.org 4 November 2014 | Volume 9 | Issue 11 | e112653
and 18 articles only described the characteristics of the study
design (i.e. experimental, prospective, multicenter, etc) without
specifying which study design was used (Table 1).
The response variable (‘clinical’) of the study differed in each of
the reviewed articles, and thus there was no common illness or
pathology. Available software can fit different response variables
Figure 2. Number of reviewed articles by year of publication.
doi:10.1371/journal.pone.0112653.g002
Table 1. Characteristics of the study design in the reviewed articles.
N=108
Longitudinal study:
NO 40 (37.0%)
Unclear 9 (8.30%)
YES 59 (54.6%)
Repeated measures:
NO 34 (31.5%)
Unclear 11 (10.2%)
YES 56 (58.3%)
Multilevel (nested design):
NO 79 (73.1%)
YES 29 (26.9%)
Type of analysis
Exploratory 81 (75.0%)
Confirmatory 27 (25.0%)
Design
Case-control 2 (2.30%)
Case-crossover 1 (1.10%)
Cluster Random Trial 18 (16.7%)
Cohorts 26 (24.1%)
Cross-sectional 31 (28.7%)
NR 8 (7.40%)
Unclear 22 (20.4%)
NR: Not reported.
doi:10.1371/journal.pone.0112653.t001
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for exponential family, such as Poisson, binomial, Gamma, and
Inverse Gaussian, though Poisson and Binomial (or binary) are the
most used in medicine. The distribution of the response variable
was reported in 88% of the articles, and the most common was
binomial (n = 64), Poisson (n = 22), negative binomial (n = 1) and
multinomial (n = 2).
Furthermore, the estimation method for each model was
reported in only 21 articles (19.4%), and the following estimation
methods were used: maximum likelihood (n = 3), penalized quasi-
likelihood (n = 8), pseudo-likelihood (n = 2), restricted maximum
likelihood (n = 2), adaptative quadrature likelihood approximation
(n = 1), and Markov chain Monte Carlo (MCMC; n = 5). It is
important to mention that over 90% of the articles did not report
the test used for the fixed nor random effects, which implies that
the section on statistical methods was insufficiently described
(Table 2).
The most used statistical software packages were SAS (n = 57),
R (n = 13), Stata (n = 12), and HLM (n = 6). For SAS, the use of
macro GLIMMIX was reported in 24 articles and the macro
NLMIXED with PROC MIXED to fit the GLMM was used in
five articles. For R, different packages were used to fit the GLMM,
such as lme4 (n = 2), glmmPQL (n = 4), glmmML(n = 1), BayesX
(n = 2) or repeated (n = 1). For Stata, the gllamm (n = 2) and
xtmixed functions were also used (n = 1).
Overdispersion for models with counts or binary response which
assume a Poisson or Binomial distribution was evaluated in 10
articles. Of these, different approaches were proposed to fit as
alternatives (GEE, Negative Binomial, Quasi-Poisson, Zero-
Inflated). For the articles that used Poisson or Binomial
distribution of probability, 90.7% did not state if under-over-
dispersion was evaluated, 99.1% did not report the magnitude of
the scale parameter, and 92.6% did not suggest alternatives for
possible under-overdispersion. Variance estimates of random
effects were described in only 10 articles (9.3%). With respect to
the fixed effects, the standard error and confidence interval were
reported in 20% and 71.3%, respectively, whereas in the variance
components, they were reported in 3.7% and 2.8%, respectively.
The model validation, the method of covariate selection and the
method of goodness of fit were reported in 6.5%, 35.2% and
15.7% of the articles, respectively (Table 3).
Discussion
The articles selected in this review showed that the number of
bibliographical references that use GLMMs in medical journals
increased from the year 2000 to 2012.
Our review also indicated that there is room for improvement in
quality when basic characteristics about the GLMMs are reported
in medical journals.
A predominance of the articles reviewed were in the fields of
environmental and occupational public health. Furthermore, for
45 of the articles (41.7%) at least one of the co-authors was
associated with a biometrics or statistical department. This result is
consistent with the systematic review of Diaz-Ordaz that showed
that trials having a statistician as co-author was associated with a
increase in the methodological quality of the analyses [56].
In any scientific paper, the validity of the conclusions is linked to
the adequacy of the methods used to generate the results. Thus, it
is important to adequately describe the statistical methods used in
the analysis. Hence, the reader is able to judge whether the
methods used are appropriate, and by extension whether the
conclusions are correct.
In the case of GLMM’s, as we observed in the results section,
the majority of the useful and relevant information about GLMMs
that is proposed by Bolker [19] and Thiele [22] was not reported.
Therefore, the main consequence is the difficulty to assess the
reliability of the results and the validity of the conclusions. For
example, the majority of the articles did not mention the
estimation method or software that was used. The inferential
issues (hypothesis testing, confidence interval estimation) and
model validation are closely linked to the estimation method (for
instance, bayesian or frequentist). As a consequence, the lack of
reporting of the estimation method (or software) used makes it
complicated to evaluate the adequacy of the approaches used to
inference purposes. Furthermore, the estimation method may have
important flaws depending on the situation. For example, PQL
yields biased parameter estimates if the standard deviations of the
random effects are large, especially with binary data [19].
Additionally, an important deficit regarding the inference of
fixed and random effects was observed. Such inference may consist
of : 1) hypothesis testing of a set of parameters; 2) competing
models using entropy measures; 3) confidence interval of
parameters. Here again the validity of the conclusions drawn
from the analysis depends on the appropriateness of the
procedures used in the inference. For example, the likelihood
ratio test is only applicable to nested models. Another example
arises when testing the existence of a random effect. This question
could be solved by a common hypothesis testing using a null
hypothesis whose variance is zero. However, the null hypothesis is
set to the boundary of the parameter domain (variance must be
positive). Therefore, it is necessary to modify the probability
distribution function under the null hypothesis otherwise the p-
value obtained is incorrect [57]. Additionally, as we mentioned
above, the inferential procedures must be coherent with the
estimation technique used.
Furthermore, the validity and model selection as proposed by
Bolker and Thiele [19,22] were also not reported in most cases.
Once again, the results of the inference and the conclusions of the
study will be valid when the assumptions made on the model and
estimation method are fulfilled. This is the aim of the validation
and, thus, it is essential that the researchers report the results of
such a validation and how it was made.
Therefore, in our opinion the methodological information
reported in articles using GLMMs could be improved.
We also think that standardized guidelines to report GLMM
characteristics in medicine could be beneficial, even though they
would not imply by themselves a direct improvement on quality of
the articles. As stated by Cobo [35] and Moher [58], it is necessary
that both authors and reviewers are aware of recommendations to
improve the quality of the manuscripts.
Limitations of the study
One of the limitations of our study could be that the number of
identified articles was not high, despite the 13-years review.
Nonetheless, the only similar existing review by Thiele [22] in the
field of ‘‘invasion biology’’ included only 50 articles. One possible
explanation for this number of articles that use GLMMs in health
sciences is that medical literature frequently uses models with fixed
effects in a hierarchical structure, even though the use of GLMMs
is well known in statistical literature [6,59].
Another possible limitation of our review is the potential bias to
disregard articles that use a GLMM but do not specify the term as
a topic. However, we could assume that articles that use GLMM
as topic are more sensitive to this methodology. Thus, it is
expected that if this bias existed, the reporting quality would be
even better in those potential articles that applied GLMM and
used it as a topic.
A Systematic Review of GLMMs in Clinical Medicine
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There could be also a trend on the estimation methods
according to the names given to GLMMs in the articles. Bayesians
usually prefer the term hierarchical models instead of mixed effects
models whereas frequentists are more likely to use mixed models,
which seems to be consistent with our results (Appendix S4).
Conclusions
During recent years, the use of GLMMs in medical literature
has increased to take into account the correlation of data when
modeling binary or count data. Our review included articles from
indexed medical journals included in JCR that mainly consisted of
longitudinal studies in a medical setting.
Table 2. Characteristics of inference and estimation methods reported in the review articles.
N=108
Test for fixed effects:
NR 103 (95.4%)
t-value 1 (0.90%)
Wald F test 4 (3.7%)
Test for random effects:
LRT 3 (2.80%)
NR 105 (97.2%)
Variance estimates of random effects:
NR 98 (90.7%)
YES 10 (9.30%)
Statistical software:
SAS 57 (52.8%)
R 13 (12.0%)
Stata 12 (11.1%)
WinBugs 2 (1.90%)
S-plus 3 (2.80%)
HLM 6 (5.60%)
Statistical Analysis System 1 (0.90%)
SPSS 2 (1.90%)
SEER*Stat 1 (0.90%)
MLwiN 1 (0.90%)
NR 10 (9.30%)
Estimation method:
Adaptative Quadrature likelihood Approximation 1 (0.90%)
Maximum Likelihood 3 (2.80%)
NR 87 (80.6%)
Penalized Quasi- likelihood 8 (7.50%)
Posterior mean 5 (4.60%)
Restricted Maximum Likelihood 2 (1.90%)
Pseudo likelihood 2 (1.90%)
Statistical software function or macro:
PROC GLIMMIX 24 (22.2%)
glmmPQL 4 (3.70%)
Gllamm 2 (1.90%)
BayesX 2 (1.90%)
Xtmixed 1 (0.90%)
PROC MIXED/NLMIXED 5 (4.70%)
lme4 2 (1.90%)
glmmML 1 (0.90%)
Repeated 1 (0.90%)
NR 66 (61.1%)
NR: No reported; MCMC: Markov chain Monte Carlo.
doi:10.1371/journal.pone.0112653.t002
A Systematic Review of GLMMs in Clinical Medicine
PLOS ONE | www.plosone.org 7 November 2014 | Volume 9 | Issue 11 | e112653
According to the current recommendations, the quality of
reporting has room for improvement regarding the characteristics
of the analysis, estimation method, validation and selection of the
model.
After analyzing and reviewing the quality of the publications, we
believe it is important to consider the use of minimal rules as
standardized guidelines when presenting GLMM results in
medical journals.
Table 3. Characteristics of the specification, validation and construction of the model for the reviewed articles.
N=108
Variable response distribution:
2 distributions: Binomial, Poisson 1 (0.90%)
2 distributions: Binomial, Multinomial 1 (0.90%)
Binomial 64 (59.2%)
Binomial count 1 (0.90%)
Negative Binomial with offset 1 (0.90%)
NR 11 (10.2%)
Poisson 22 (20.4%)
Poisson with offset 2 (1.90%)
Multinomial 2 (1.90%)
Ordinal 1 (0.90%)
Unclear 2 (1.90%)
Overdispersion evaluation:
NR 98 (90.7%)
YES 10 (9.20%)
Overdispersion measurement:
NR 107 (99.1%)
Pearson residuals 1 (0.90%)
Proposed alternative for overdispersion:
GEE 2 (1.90%)
Negative Binomial 2 (1.90%)
NR 100 (92.6%)
Quasi-Poisson 1 (0.90%)
Variogram 1 (0.90%)
Dscale-adjusted 1 (0.90%)
Zero-inflated 1 (0.90%)
Method of variable selection:
Backward 3 (2.80%)
Forward 1 (0.90%)
Forward stepwise 1 (0.90%)
NR 70 (64.8%)
Unnecessary (Confirmatory analysis) 27 (25.0%)
Stepwise 6 (5.60%)
Method of goodness of fit comparison model:
AIC 12 (11.1%)
BIC 3 (2.80%)
DIC 1 (0.90%)
NR 91 (84.3%)
Pseudo R-squared 1 (0.90%)
GLMM Validation:
NR 101 (93.5%)
YES 7 (6.50%)
NR: No reported; MCMC: Markov chain Monte Carlo; GEE: Generalized estimating equation;
DIC: Deviance information criterion; AIC: Akaike information criterion; BIC: Bayesian information criterion; df: freedom degree.
doi:10.1371/journal.pone.0112653.t003
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